Company news
Castle Biosciences, Inc. news in 2019
Castle Biosciences, Inc.'s news releases, calls and decks from 2019, newest first.
Castle Biosciences Announces Level of Evidence Review on DecisionDx-Melanoma Published in Latest Issue of American Journal of Clinical Dermatology
December 29, 2019
Castle Biosciences Announces Time Change for Presentation at the Evercore ISI Second Annual HealthCONx
December 2, 2019
Castle Biosciences Presents Expanded Data Supporting Use of DecisionDx-Melanoma Test to Inform Sentinel Lymph Node Biopsy Recommendations
November 24, 2019
Castle Biosciences Reports Third Quarter 2019 Results
November 10, 2019
Castle Biosciences Presents Clinical Validation Study for its Cutaneous Squamous Cell Carcinoma Prognostic Test at the American Society for Dermatologic Surgery (ASDS) 2019 Annual Meeting
October 28, 2019
Castle Biosciences to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 11, 2019
October 27, 2019
Castle Biosciences Announces Presentation of Prospective, Multicenter Study Demonstrating Significant Impact of DecisionDx-UM on Treatment Plan Recommendations for Patients with Uveal Melanoma
October 15, 2019
Castle Biosciences Added to Membership of US Small-Cap Russell 2000® Index
September 18, 2019
Decks in 2019
- Q3 2019 Earnings Presentation
Earnings · 29 slides · Nov 14, 2019